<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dermatology Quick Reference Tool</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --urgent-red: #ffebee;
            --urgent-border: #f44336;
            --urgent-text: #b71c1c;
            --safe-green: #e8f5e9;
            --safe-border: #4caf50;
            --safe-text: #1b5e20;
            --info-blue: #e3f2fd;
            --info-border: #2196f3;
            --info-text: #0d47a1;
            --neutral-gray: #f5f5f5;
            --neutral-border: #9e9e9e;
            --card-shadow: 0 4px 8px rgba(0,0,0,0.1);
            --transition: all 0.3s ease;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: #f9f9f9;
            color: #333;
            line-height: 1.5;
            padding: 20px;
            max-width: 1400px;
            margin: 0 auto;
        }
        
        header {
            text-align: center;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 2px solid #e0e0e0;
        }
        
        h1 {
            color: #2c3e50;
            margin-bottom: 10px;
            font-size: 2.2rem;
        }
        
        .subtitle {
            color: #546e7a;
            font-size: 1.1rem;
            max-width: 800px;
            margin: 0 auto;
        }
        
        .alert-banner {
            background-color: var(--urgent-red);
            border-left: 6px solid var(--urgent-border);
            padding: 15px;
            margin: 20px 0;
            border-radius: 4px;
            display: flex;
            align-items: center;
            animation: pulse 2s infinite;
        }
        
        @keyframes pulse {
            0% { box-shadow: 0 0 0 0 rgba(244, 67, 54, 0.4); }
            70% { box-shadow: 0 0 0 10px rgba(244, 67, 54, 0); }
            100% { box-shadow: 0 0 0 0 rgba(244, 67, 54, 0); }
        }
        
        .alert-banner i {
            color: var(--urgent-border);
            font-size: 1.5rem;
            margin-right: 15px;
        }
        
        .main-container {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(350px, 1fr));
            gap: 25px;
            margin-bottom: 30px;
        }
        
        .condition-card {
            background: white;
            border-radius: 8px;
            box-shadow: var(--card-shadow);
            overflow: hidden;
            transition: var(--transition);
            display: flex;
            flex-direction: column;
            height: 100%;
        }
        
        .condition-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 16px rgba(0,0,0,0.15);
        }
        
        .card-header {
            padding: 15px 20px;
            border-bottom: 1px solid #eee;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        
        .card-header h3 {
            color: #2c3e50;
            font-size: 1.3rem;
        }
        
        .card-tag {
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: bold;
        }
        
        .urgent-tag {
            background-color: var(--urgent-red);
            color: var(--urgent-text);
            border: 1px solid var(--urgent-border);
        }
        
        .safe-tag {
            background-color: var(--safe-green);
            color: var(--safe-text);
            border: 1px solid var(--safe-border);
        }
        
        .card-content {
            padding: 20px;
            flex-grow: 1;
        }
        
        .card-section {
            margin-bottom: 20px;
        }
        
        .section-title {
            font-weight: 600;
            margin-bottom: 8px;
            display: flex;
            align-items: center;
            color: #37474f;
        }
        
        .section-title i {
            margin-right: 8px;
        }
        
        .urgent-section {
            background-color: var(--urgent-red);
            border: 1px solid var(--urgent-border);
            border-radius: 6px;
            padding: 15px;
        }
        
        .safe-section {
            background-color: var(--safe-green);
            border: 1px solid var(--safe-border);
            border-radius: 6px;
            padding: 15px;
        }
        
        .info-section {
            background-color: var(--info-blue);
            border: 1px solid var(--info-border);
            border-radius: 6px;
            padding: 15px;
        }
        
        .key-points {
            list-style-type: none;
        }
        
        .key-points li {
            padding: 6px 0;
            position: relative;
            padding-left: 24px;
        }
        
        .key-points li:before {
            content: "•";
            position: absolute;
            left: 0;
            color: #546e7a;
            font-weight: bold;
        }
        
        .red-flag {
            color: var(--urgent-text);
            font-weight: bold;
        }
        
        .treatment-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 10px;
        }
        
        .treatment-table th, .treatment-table td {
            padding: 10px;
            text-align: left;
            border-bottom: 1px solid #e0e0e0;
        }
        
        .treatment-table th {
            background-color: #f5f5f5;
            font-weight: 600;
        }
        
        .treatment-table tr:hover {
            background-color: #f9f9f9;
        }
        
        .quick-ref-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
            gap: 20px;
            margin-top: 30px;
        }
        
        .ref-card {
            background: white;
            border-radius: 8px;
            padding: 20px;
            box-shadow: var(--card-shadow);
        }
        
        .footer {
            text-align: center;
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #e0e0e0;
            color: #546e7a;
            font-size: 0.9rem;
        }
        
        .search-box {
            margin: 20px 0;
            text-align: center;
        }
        
        .search-box input {
            width: 100%;
            max-width: 500px;
            padding: 12px 20px;
            border: 2px solid #ddd;
            border-radius: 30px;
            font-size: 1rem;
            transition: var(--transition);
        }
        
        .search-box input:focus {
            outline: none;
            border-color: var(--info-border);
        }
        
        .highlight {
            background-color: #fff9c4;
            padding: 2px 4px;
            border-radius: 3px;
        }
        
        @media (max-width: 768px) {
            .main-container {
                grid-template-columns: 1fr;
            }
            
            .quick-ref-grid {
                grid-template-columns: 1fr;
            }
            
            h1 {
                font-size: 1.8rem;
            }
        }
    </style>
</head>
<body>
    <header>
        <h1><i class="fas fa-stethoscope"></i> Dermatology Quick Reference Tool</h1>
        <p class="subtitle">Critical information for inflammatory skin conditions with visual urgency indicators. Red for emergencies, green for safe actions, blue for general information.</p>
        
        <div class="alert-banner">
            <i class="fas fa-exclamation-triangle"></i>
            <div>
                <strong>RED FLAG ALERTS:</strong> Erythroderma (>90% skin involvement), failure to respond to appropriate therapy, progressive symptoms, systemic symptoms, recurrent severe infections, unusual distribution.
            </div>
        </div>
    </header>
    
    <div class="search-box">
        <input type="text" id="searchInput" placeholder="Search conditions, symptoms, or treatments...">
    </div>
    
    <div class="main-container">
        <!-- Eczema Card -->
        <div class="condition-card" data-condition="eczema">
            <div class="card-header">
                <h3>Eczema (Atopic Dermatitis)</h3>
                <span class="card-tag safe-tag">Common</span>
            </div>
            <div class="card-content">
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-info-circle"></i> Overview</div>
                    <p>Chronic, relapsing-remitting course with epidermal barrier defect. 20% children, 3% adults. DH2 immune dysregulation.</p>
                </div>
                
                <div class="card-section urgent-section">
                    <div class="section-title"><i class="fas fa-exclamation-circle"></i> Red Flags</div>
                    <ul class="key-points">
                        <li><span class="red-flag">Failure to respond to appropriate therapy</span></li>
                        <li><span class="red-flag">Progressive erythroderma</span> (>90% skin involvement)</li>
                        <li><span class="red-flag">Recurrent severe infections</span></li>
                        <li><span class="red-flag">Systemic symptoms</span></li>
                        <li><span class="red-flag">Consider cutaneous T-cell lymphoma if unresponsive</span></li>
                    </ul>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-check-circle"></i> Management</div>
                    <table class="treatment-table">
                        <tr>
                            <th>Severity</th>
                            <th>Treatment</th>
                        </tr>
                        <tr>
                            <td>Mild</td>
                            <td>Emollients, mild steroids (1% hydrocortisone for face/flexures)</td>
                        </tr>
                        <tr>
                            <td>Moderate</td>
                            <td>Moderate potency steroids (clobetasone), topical calcineurin inhibitors</td>
                        </tr>
                        <tr>
                            <td>Severe</td>
                            <td>Potent steroids, phototherapy, systemic immunosuppressants, biologics (dupilumab)</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>
        
        <!-- Psoriasis Card -->
        <div class="condition-card" data-condition="psoriasis">
            <div class="card-header">
                <h3>Psoriasis</h3>
                <span class="card-tag urgent-tag">CVS Risk</span>
            </div>
            <div class="card-content">
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-info-circle"></i> Overview</div>
                    <p>Hyperproliferative disorder of keratinocytes. Associated with cardiovascular risk, metabolic syndrome, psoriatic arthritis.</p>
                </div>
                
                <div class="card-section urgent-section">
                    <div class="section-title"><i class="fas fa-exclamation-circle"></i> Red Flags & Referral</div>
                    <ul class="key-points">
                        <li><span class="red-flag">Erythrodermic psoriasis</span> - medical emergency</li>
                        <li><span class="red-flag">Generalized pustular psoriasis</span></li>
                        <li><span class="red-flag">Failure to respond to topical therapy</span></li>
                        <li><span class="red-flag">Arthritis symptoms</span> (use PEST score ≥2 → rheumatology)</li>
                    </ul>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-check-circle"></i> Management</div>
                    <ul class="key-points">
                        <li><strong>Topical:</strong> Corticosteroids + vitamin D analogs (calcipotriol)</li>
                        <li><strong>Moderate:</strong> Narrowband UVB phototherapy</li>
                        <li><strong>Severe:</strong> Systemic (methotrexate, cyclosporin, acitretin*) or biologics</li>
                        <li><small>*Acitretin: Teratogenic, avoid in women of childbearing age</small></li>
                    </ul>
                </div>
            </div>
        </div>
        
        <!-- Acne Vulgaris Card -->
        <div class="condition-card" data-condition="acne">
            <div class="card-header">
                <h3>Acne Vulgaris</h3>
                <span class="card-tag safe-tag">Common</span>
            </div>
            <div class="card-content">
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-info-circle"></i> Overview</div>
                    <p>Four pathogenic factors: follicle hyperkeratinization, sebum production, inflammation, C. acnes proliferation.</p>
                </div>
                
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-clipboard-list"></i> Assessment</div>
                    <ul class="key-points">
                        <li>Distribution: face, neck, chest, back</li>
                        <li>Scarring assessment: atrophic/hypertrophic/keloids</li>
                        <li>Psychosocial impact</li>
                        <li>Trigger identification</li>
                    </ul>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-check-circle"></i> Management</div>
                    <table class="treatment-table">
                        <tr>
                            <th>Type</th>
                            <th>Treatment</th>
                        </tr>
                        <tr>
                            <td>Comedonal</td>
                            <td>Topical retinoids (adapalene) or benzoyl peroxide</td>
                        </tr>
                        <tr>
                            <td>Inflammatory</td>
                            <td>Topical retinoid + BP ± topical antibiotic (limit 8-12 weeks)</td>
                        </tr>
                        <tr>
                            <td>Moderate-Severe</td>
                            <td>Oral tetracyclines + topical therapy</td>
                        </tr>
                        <tr>
                            <td>Nodulocystic</td>
                            <td>Isotretinoin* (secondary care)</td>
                        </tr>
                    </table>
                    <p><small>*Isotretinoin: Pregnancy prevention program, monitor LFTs/lipids, photosensitivity</small></p>
                </div>
            </div>
        </div>
        
        <!-- Urticaria & Angioedema Card -->
        <div class="condition-card" data-condition="urticaria">
            <div class="card-header">
                <h3>Urticaria & Angioedema</h3>
                <span class="card-tag urgent-tag">Acute</span>
            </div>
            <div class="card-content">
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-info-circle"></i> Classification</div>
                    <ul class="key-points">
                        <li><strong>Acute:</strong> < 6 weeks duration</li>
                        <li><strong>Chronic:</strong> ≥ 6 weeks duration</li>
                        <li>Pathophysiology: Mast cell degranulation (histamine release)</li>
                        <li>Triggers rare in CSU despite patient beliefs</li>
                    </ul>
                </div>
                
                <div class="card-section urgent-section">
                    <div class="section-title"><i class="fas fa-exclamation-circle"></i> Emergency: Angioedema</div>
                    <ul class="key-points">
                        <li><span class="red-flag">Swelling of eyelids, lips, tongue, pharynx</span></li>
                        <li><span class="red-flag">Potential airway compromise</span></li>
                        <li>Urgent assessment required</li>
                    </ul>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-check-circle"></i> Management</div>
                    <ul class="key-points">
                        <li><strong>First-line:</strong> Antihistamines (non-sedating)</li>
                        <li><strong>Severe acute:</strong> Short course oral corticosteroids (0.5-0.75 mg/kg)</li>
                        <li><strong>Refractory chronic:</strong> Omalizumab (biologic)</li>
                        <li><strong>Pregnancy:</strong> Cyclosporin considered safe</li>
                    </ul>
                </div>
            </div>
        </div>
        
        <!-- Scabies Card -->
        <div class="condition-card" data-condition="scabies">
            <div class="card-header">
                <h3>Scabies</h3>
                <span class="card-tag urgent-tag">Infectious</span>
            </div>
            <div class="card-content">
                <div class="card-section urgent-section">
                    <div class="section-title"><i class="fas fa-exclamation-circle"></i> Key Presentation</div>
                    <ul class="key-points">
                        <li><span class="red-flag">Intense pruritus worse at night</span></li>
                        <li>Burrows in web spaces, wrists, ankles, genitals, nipples</li>
                        <li>Norwegian scabies: crusted, highly contagious form</li>
                        <li>Commonly misdiagnosed as psoriasis/eczema</li>
                    </ul>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-check-circle"></i> Management</div>
                    <ul class="key-points">
                        <li><strong>First-line:</strong> Permethrin 5% cream</li>
                        <li>Day 1: Apply all over body, leave for 8-12 hours</li>
                        <li>Day 7: Repeat application</li>
                        <li>Treat all close contacts simultaneously</li>
                        <li>Decontaminate clothing/bedding</li>
                        <li><strong>Resistant cases:</strong> Add oral ivermectin 200μg/kg</li>
                    </ul>
                </div>
                
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-clock"></i> Note on Post-Scabietic Itch</div>
                    <p>Can persist 2-6 weeks after successful treatment. Differentiate from active infection (burrows present).</p>
                </div>
            </div>
        </div>
        
        <!-- Skin of Color Considerations Card -->
        <div class="condition-card" data-condition="skin color">
            <div class="card-header">
                <h3>Skin of Color Considerations</h3>
                <span class="card-tag info-section">Important</span>
            </div>
            <div class="card-content">
                <div class="card-section info-section">
                    <div class="section-title"><i class="fas fa-info-circle"></i> Key Differences</div>
                    <ul class="key-points">
                        <li><strong>Erythema:</strong> Less apparent; may appear purplish/dark</li>
                        <li><strong>Post-inflammatory:</strong> Hyper/hypopigmentation common, can last months-years</li>
                        <li><strong>Follicular disorders:</strong> Pseudofolliculitis barbae more common</li>
                        <li><strong>Keloid scarring:</strong> Higher risk</li>
                    </ul>
                </div>
                
                <div class="card-section">
                    <div class="section-title"><i class="fas fa-prescription-bottle"></i> Steroid Caution</div>
                    <p>Avoid unnecessary high-potency steroids to reduce risk of atrophy, telangiectasia, and pigment changes.</p>
                </div>
                
                <div class="card-section safe-section">
                    <div class="section-title"><i class="fas fa-hand-holding-medical"></i> Management Tips</div>
                    <ul class="key-points">
                        <li>Reassure about post-inflammatory changes - slow to resolve</li>
                        <li>Pseudofolliculitis: Avoid close shaving, single-blade razors, shave with hair growth</li>
                        <li>Consider topical retinoids, glycolic/salicylic acid for ingrown hairs</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    
    <div class="quick-ref-grid">
        <div class="ref-card">
            <h3><i class="fas fa-skull-crossbones"></i> Immediate Referral Indicators</h3>
            <ul class="key-points">
                <li><span class="red-flag">Erythroderma</span> (>90% skin involvement)</li>
                <li><span class="red-flag">Acute blistering disorders</span> (SJS/TEN)</li>
                <li><span class="red-flag">Pustular psoriasis</span></li>
                <li><span class="red-flag">Eczema herpeticum</span> (HSV infection in eczema)</li>
                <li><span class="red-flag">Systemic symptoms</span> with skin findings</li>
                <li><span class="red-flag">Suspected cutaneous T-cell lymphoma</span> (unresponsive eczema/psoriasis)</li>
            </ul>
        </div>
        
        <div class="ref-card">
            <h3><i class="fas fa-prescription-bottle-alt"></i> Topical Steroid Potency</h3>
            <table class="treatment-table">
                <tr>
                    <th>Potency</th>
                    <th>Examples</th>
                    <th>Use</th>
                </tr>
                <tr>
                    <td>Mild</td>
                    <td>Hydrocortisone 1%</td>
                    <td>Face, flexures, genitals</td>
                </tr>
                <tr>
                    <td>Moderate</td>
                    <td>Clobetasone (Eumovate)</td>
                    <td>Trunk, limbs</td>
                </tr>
                <tr>
                    <td>Potent</td>
                    <td>Betamethasone valerate</td>
                    <td>Localized areas, short courses</td>
                </tr>
                <tr>
                    <td>Very Potent</td>
                    <td>Clobetasol propionate (Dermovate)</td>
                    <td>Resistant areas, supervised use</td>
                </tr>
            </table>
        </div>
        
        <div class="ref-card">
            <h3><i class="fas fa-lightbulb"></i> Clinical Pearls</h3>
            <ul class="key-points">
                <li><strong>Tinea incognito:</strong> Fungal infection masked by steroid use</li>
                <li><strong>Koebner phenomenon:</strong> Trauma-induced lesions (psoriasis, lichen planus)</li>
                <li><strong>Auspitz sign:</strong> Pinpoint bleeding when scale removed (psoriasis)</li>
                <li><strong>Norwegian scabies:</strong> Crusted, highly contagious form in immunocompromised</li>
                <li><strong>Herald patch:</strong> Solitary oval plaque preceding pityriasis rosea</li>
                <li><strong>Topical antibiotic resistance:</strong> Limit to 8-12 weeks, combine with benzoyl peroxide</li>
            </ul>
        </div>
    </div>
    
    <div class="footer">
        <p>Clinical Dermatology Quick Reference Tool | Based on dermatology educational session transcript</p>
        <p><i class="fas fa-info-circle"></i> For educational purposes only. Always consult current guidelines for clinical decisions.</p>
    </div>

    <script>
        // Search functionality
        document.getElementById('searchInput').addEventListener('input', function(e) {
            const searchTerm = e.target.value.toLowerCase().trim();
            const cards = document.querySelectorAll('.condition-card');
            
            if (searchTerm === '') {
                cards.forEach(card => {
                    card.style.display = 'flex';
                    removeHighlights(card);
                });
                return;
            }
            
            cards.forEach(card => {
                const cardText = card.textContent.toLowerCase();
                const condition = card.getAttribute('data-condition');
                
                if (cardText.includes(searchTerm) || condition.includes(searchTerm)) {
                    card.style.display = 'flex';
                    highlightText(card, searchTerm);
                } else {
                    card.style.display = 'none';
                }
            });
        });
        
        function highlightText(element, term) {
            removeHighlights(element);
            
            if (term.length < 2) return;
            
            const regex = new RegExp(`(${term})`, 'gi');
            const walker = document.createTreeWalker(
                element, 
                NodeFilter.SHOW_TEXT, 
                null, 
                false
            );
            
            let node;
            const nodes = [];
            
            while (node = walker.nextNode()) {
                nodes.push(node);
            }
            
            nodes.forEach(node => {
                const parent = node.parentNode;
                if (parent.nodeName === 'MARK' || parent.classList.contains('highlight')) {
                    return;
                }
                
                const html = node.nodeValue.replace(regex, '<mark class="highlight">$1</mark>');
                const newSpan = document.createElement('span');
                newSpan.innerHTML = html;
                parent.replaceChild(newSpan, node);
            });
        }
        
        function removeHighlights(element) {
            const highlights = element.querySelectorAll('.highlight');
            highlights.forEach(highlight => {
                const parent = highlight.parentNode;
                parent.replaceChild(document.createTextNode(highlight.textContent), highlight);
                parent.normalize();
            });
        }
        
        // Add hover animations to cards
        document.querySelectorAll('.condition-card').forEach(card => {
            card.addEventListener('mouseenter', function() {
                this.style.transform = 'translateY(-5px)';
                this.style.boxShadow = '0 8px 16px rgba(0,0,0,0.15)';
            });
            
            card.addEventListener('mouseleave', function() {
                this.style.transform = 'translateY(0)';
                this.style.boxShadow = '0 4px 8px rgba(0,0,0,0.1)';
            });
        });
        
        // Emergency alert banner animation
        const alertBanner = document.querySelector('.alert-banner');
        setInterval(() => {
            alertBanner.style.transform = alertBanner.style.transform === 'scale(1.01)' ? 'scale(1)' : 'scale(1.01)';
        }, 2000);
    </script>
</body>
</html>